The official open access journal of EHA
HemaSphere, the official open access journal of EHA, aims to support hematology researchers by offering a fast and constructive review process and low publication fees. The journal publishes basic, translational and clinical research of very high level as well as insightful review articles with recommendations for future research and clinical applications.
- SCIENCE CITATION INDEX EXPANDED (SCIE) - Hematology
- CC/CLINICAL MEDICINE - Hematology
- Essential Science Indicators - Clinical Medicine
As a newer journal, HemaSphere does not yet have an Impact Factor (Clarivate), but citations to individual articles can be followed in Web of Science. Clarivate recently completed an evaluation of HemaSphere using the Web of Science selection criteria, and their editors found HemaSphere continues to meet quality criteria and now also meets impact criteria. As such, HemaSphere is expecting its first Impact Factor in June 2022.
HemaSphere is indexed in Scopus with a CiteScore of 5.4 (April 2022) - CiteScore is using a 4-year window to track citations and is updated monthly.
Read the latest articles
Discover our collection of open access articles published in HemaSphere.
Explore our collection of Review articles published by HemaSphere.
Submit your paper
EHA members have the opportunity to publish for a discounted fee in HemaSphere.